We and others have previously shown that during acute and chronic HIV infection of BLT-humanized mice, IFNα14 treatment resulted in significantly reduced viremia and the treatment did not induce hyperimmune activation (2, 11, 12, 31). The gene discussed is IFNA14; the disease is HIV infectious disease.